- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on High-Risk Resectable NSCLC
Total 622 results
-
Archivel Farma S.L.Fundació Institut Germans Trias i PujolCompletedHigh-Risk Non-Muscle-Invasive Bladder CancerSpain
-
RemeGen Co., Ltd.Not yet recruitingHigh-risk Non-muscle Invasive Bladder CancerChina
-
Medical College of WisconsinAdvancing a Healthier Wisconsin Endowment; Food for Health, Inc.Not yet recruitingPreeclampsia | Gestational Diabetes | High Risk Pregnancy | Gestational Hypertension
-
University of California, San FranciscoJazz PharmaceuticalsNot yet recruitingThrombotic Microangiopathies | Neuroblastoma | High-risk Neuroblastoma | Transplant-Associated Thrombotic MicroangiopathyUnited States
-
Vincerx Pharma, Inc.RecruitingAcute Myeloid Leukemia | B-cell Acute Lymphoblastic Leukemia | High-risk Myelodysplastic SyndromeUnited States
-
IRCCS San RaffaeleRecruitingRheumatic Diseases | Pregnancy Complications | Pregnancy, High Risk | Preeclampsia | Immunologic Disease | Antiphospholipid Antibody Syndrome PrimaryItaly
-
Cedars-Sinai Medical CenterUniversity of California, Los Angeles; National Institutes of Health (NIH); Maternal... and other collaboratorsRecruitingDepression | Inflammation | Stress, Psychological | Pregnancy Complications | Depression, Postpartum | Anxiety | Pregnancy Related | Pregnancy, High Risk | Discrimination, Racial | Perinatal Depression | Anxiety in Pregnancy | RacismUnited States
-
iCell Gene TherapeuticsiCar Bio TherapeuticsRecruitingRelapsed/Refractory, High Risk Hematologic Malignancies | T-ALL/LymphomaChina
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedAggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced NeutropeniaGermany, Italy, Spain
-
Association for Innovation and Biomedical Research...CompletedDiabetes Mellitus Type II | Diabetes Mellitus Type I | High Risk Proliferative Diabetic RetinopathyPortugal
-
Promyco DiagnosticsSoroka University Medical CenterUnknownPreterm Labor | High Risk Pregnancy | Genital Mycoplasma InfectionIsrael
-
Dana-Farber Cancer InstituteRecruitingLung Cancer | Cirrhosis | Barrett Esophagus | Hematologic Malignancy | Non-Alcoholic Fatty Liver Disease | Cancer Risk | Vulvar Intraepithelial Neoplasia | Childhood Cancer Survivors | Lung; Node | Non Alcoholic Steatohepatitis | Osteochondroma | Cancer Predisposition Syndrome | Hereditary Cancer Prediction | Adult... and other conditionsUnited States
-
European Institute of OncologyRecruitingAnal Cancer | High-Risk Cancer | Anal Intraepithelial Neoplasia 2 | Anal Intraepithelial Neoplasia 1Italy
-
Shanghai Hengrui Pharmaceutical Co., Ltd.RecruitingHigh-risk Non-muscle Invasive Bladder CancerChina
-
Qing XIeRecruitingChronic Hepatitis B | Intermediate to High Risk of HCCChina
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | High-risk Myelodysplastic Syndrome | Myeloproliferative Neoplasm, Unclassifiable | Secondary Myelofibrosis in Myeloproliferative Disease
-
University of Modena and Reggio EmiliaUnknownExercise Addiction | Dietary Modification | High-Risk Pregnancy | Gestational Diabetes Mellitus in Pregnancy, Diet- ControlledItaly
-
Bellicum PharmaceuticalsWithdrawnMyelodysplastic Syndromes | Leukemia | Multiple Myeloma | Lymphomas | Other High-risk Hematological Malignancies
-
Fox Chase Cancer CenterCompletedMuscle Invasive Bladder Cancer | High Risk Urothelial Carcinoma of the Upper Urinary TractsUnited States
-
Prokarium LtdRecruitingA Phase 1/1b Study of ZH9 Treatment in Patients With Non-Muscle Invasive Bladder Cancer (PARADIGM-1)NMIBC | Non Muscle Invasive Bladder Cancer | High Risk NMIBCUnited States
-
University of AarhusAarhus University Hospital; Aalborg University Hospital; The University of QueenslandRecruitingDiabetes Mellitus, Type 2 | Insulin Resistance | Pregnancy, High Risk | Overweight and Obesity | Insulin Sensitivity | Gestational Diabetes | Pregnancy in DiabeticDenmark
-
Asan Medical CenterMedtronicRecruitingCryptogenic Stroke | High Risk Patent Foramen OvaleKorea, Republic of
-
University of British ColumbiaWithdrawnBladder Cancer | High-Risk Cancer | Durvalumab | Non-muscle Invasive | TremelimumabCanada
-
University Hospital, Clermont-FerrandCompletedIntensive Care Unit | Population at High Risk for ARDS DevelopmentFrance
-
Miquel Angel Pavon RibasCatalan Institute of Health; Hospital del MarRecruitingCervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III) | Human Papillomavirus (HPV) Infections | High-risk HPV | HPV-16/ 18Spain
-
University of AarhusOdense University Hospital; Aarhus University Hospital; Aalborg University Hospital and other collaboratorsRecruitingDiabetes Mellitus, Type 2 | Insulin Resistance | Pregnancy, High Risk | Overweight and Obesity | Insulin Sensitivity | Gestational Diabetes | Pregnancy in DiabeticDenmark
-
Merck Sharp & Dohme LLCRecruitingHigh-risk Non-muscle Invasive Bladder CancerCanada, Belgium, United States, Australia, Austria, France, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Netherlands, Norway, Peru, Poland, Portugal, Spain, Switzerland, Turkey, United Kingdom, China, Brazil, Co... and more
-
Angle plcMidLantic Urology, LLCTerminatedProstate Cancer | Castration-resistant Prostate Cancer | Biochemically Recurrent Prostate Carcinoma | High Risk Prostate CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | High Risk Myelodysplastic Syndrome | Myeloproliferative Neoplasm | Chronic Myelomonocytic Leukemia-2United States
-
Maastricht University Medical CenterActive, not recruitingSquamous Cell Carcinoma of the Head and Neck | Squamous Cell Carcinoma of Head and Neck | Skin Cancer | Patient Satisfaction | Decision Making | Squamous Cell Carcinoma | Cutaneous Squamous Cell Carcinoma of the Head and Neck | Cutaneous Squamous Cell Carcinoma | High-Risk Cancer | Preference, Patient | I...Netherlands
-
Sellas Life Sciences GroupUnknownMultiple Myeloma | Minimal Residual Disease | High-Risk CancerUnited States
-
Atara BiotherapeuticsMemorial Sloan Kettering Cancer CenterCompletedEBV-induced Lymphomas | EBV-associated Malignancies | Transplant Patients With EBV Viremia at High Risk for Developing a Recurrent EBV LymphomaUnited States
-
M.D. Anderson Cancer CenterRecruitingAcute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Secondary Acute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome and other conditionsUnited States
-
Universidad Politecnica de MadridPuerta de Hierro University Hospital; Hospital Vall d'Hebron; Hospital Severo... and other collaboratorsRecruitingPregnancy Complications | Pregnancy, High Risk | Maternal-Fetal Relations | Fetal Growth Retardation | Newborn Morbidity | Weight Gain, Maternal | Pregnancy Induced Hypertension | Fetus DisorderSpain
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome | High Risk Myelodysplastic Syndrome | Blasts More Than 10 Percent of Bone Marrow Nucleated CellsUnited States
-
Roswell Park Cancer InstituteCelldex TherapeuticsCompletedAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | High Risk Myelodysplastic Syndrome | Refractory Anemia | Blasts 30 Percent or Less of Bone Marrow Nucleated CellsUnited States
-
Oslo University HospitalUniversity of Oslo; Rigshospitalet, Denmark; University of Oxford; Norwegian SIDS... and other collaboratorsEnrolling by invitationPreeclampsia | High Risk Pregnancy | Hypertensive Disorder of Pregnancy | Premature Preterm Rupture of Membranes | Previous Adverse Obstetric OutcomeNorway
-
Ginna LaportTerminatedAcute Myelogenous Leukemia (AML) - Relapsed, Primary Refractory Disease or Poor Risk Factors | Chronic Myelogenous Leukemia (CML) - Accelerated or Second Chronic Phase | Myelodysplastic Syndrome (MDS) - High and Intermediate Risk | Non-Hodgkin's Lymphoma (NHL) | Chronic Lymphocytic Leukemia...United States
-
National Cancer Institute (NCI)Not yet recruitingMyelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory High Risk Myelodysplastic Syndrome
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | High Risk Myelodysplastic SyndromeUnited States
-
University of Modena and Reggio EmiliaRecruitingExercise Addiction | Dietary Modification | High-Risk Pregnancy | Gestational Diabetes Mellitus in Pregnancy, Diet- Controlled | Maternal Obesity Complicating Pregnancy, Birth,or PuerperiumItaly
-
Centre hospitalier de l'Université de Montréal...RecruitingAdvanced Non-Small Cell Lung Cancer | Unresectable Melanoma | NSCLC Stage IV | Melanoma Stage IVCanada
-
Peking University Third HospitalPeking University; The First Affiliated Hospital of Anhui Medical University; First Affiliated Hospital, Sun Yat-Sen University and other collaboratorsRecruitingPre-Eclampsia | High Risk Pregnancy | Twin Pregnancy, Antepartum Condition or Complication | Pre-Term | Twin Dichorionic Diamniotic Placenta | Twin to Twin Transfusion as Antepartum Condition | Twin Placenta | Twin Monochorionic Diamniotic PlacentaChina
-
Maastricht University Medical CenterRecruitingQuality of Life | Satisfaction, Patient | Squamous Cell Carcinoma of the Head and Neck | Squamous Cell Carcinoma of Head and Neck | Skin Cancer | Squamous Cell Carcinomas | Squamous Cell Carcinoma of the Skin | Cutaneous Squamous Cell Carcinoma of the Head and Neck | Cutaneous Squamous Cell Carcinoma | High-Risk CancerNetherlands
-
Teal Health, Inc.Enrolling by invitationHPV Infection | HPV 16 Infection | Hpv | High Risk HPVUnited States
-
GT Biopharma, Inc.TerminatedAcute Myelogenous Leukemia | Systemic Mastocytosis | Mast Cell Leukemia | High-risk Myelodysplastic SyndromesUnited States
-
University of California, DavisNational Cancer Institute (NCI); IO BiotechRecruitingStage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8 | High Risk Non-Muscle Invasive Bladder Urothelial CarcinomaUnited States
-
Threshold PharmaceuticalsCompletedAcute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | High-risk Myelodysplastic Syndrome | Advanced MyelofibrosisUnited States
-
University of Roma La SapienzaNot yet recruitingNon-muscle-invasive Bladder Cancer | Non-Muscle Invasive Bladder Urothelial Carcinoma | High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma
-
Karyopharm Therapeutics IncActive, not recruitingAcute Myeloid Leukemia (AML) | Metastatic Colorectal Cancer (mCRC) | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Relapsed/Refractory Multiple Myeloma (RRMM) | Higher-Risk Myelodysplastic Syndrome (HR-MDS) | Newly Diagnosed Intermediate/High-Risk MDSUnited States, France, Canada, Spain, China